IMS Health Holdings Inc (IMS) : Tyrian Investments reduced its stake in IMS Health Holdings Inc by 13.91% during the most recent quarter end. The investment management company now holds a total of 124,385 shares of IMS Health Holdings Inc which is valued at $3,674,333 after selling 20,100 shares in IMS Health Holdings Inc , the firm said in a disclosure report filed with the SEC on Aug 15, 2016.IMS Health Holdings Inc makes up approximately 5.48% of Tyrian Investments’s portfolio.
Other Hedge Funds, Including , Tpg-axon Management Lp sold out all of its stake in IMS during the most recent quarter. The investment firm sold 1,131,018 shares of IMS which is valued $33,410,272.Td Asset Management Inc reduced its stake in IMS by selling 1,700 shares or 1.01% in the most recent quarter. The Hedge Fund company now holds 167,100 shares of IMS which is valued at $5,001,303. IMS Health Holdings Inc makes up approx 0.01% of Td Asset Management Inc’s portfolio.Proficio Capital Partners boosted its stake in IMS in the latest quarter, The investment management firm added 54 additional shares and now holds a total of 80 shares of IMS Health Holdings Inc which is valued at $2,402.Sumitomo Mitsui Asset Management Company Ltd boosted its stake in IMS in the latest quarter, The investment management firm added 212 additional shares and now holds a total of 11,293 shares of IMS Health Holdings Inc which is valued at $339,016. IMS Health Holdings Inc makes up approx 0.01% of Sumitomo Mitsui Asset Management Company Ltd’s portfolio.
IMS Health Holdings Inc opened for trading at $29.83 and hit $29.92 on the upside on Thursday, eventually ending the session at $29.85, with a gain of 0.10% or 0.03 points. The heightened volatility saw the trading volume jump to 7,09,081 shares. Company has a market cap of $9,827 M.
On the company’s financial health, IMS Health Holdings Inc reported $0.41 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $0.38. The company had revenue of $1576.00 million for the quarter, compared to analysts expectations of $799.33 million. The company’s revenue was up 112.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.37 EPS.
IMS Health Holdings Inc. (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Companys data set contains over 10 petabytes of data and over 500 million patient records. The Company serves healthcare organizations and life science companies including pharmaceutical biotechnology consumer health and medical device manufacturers as well as distributors providers payers government agencies policymakers researchers and the financial community. The Companys principal offerings include national information offerings sub-national information offerings workflow analytics real-world evidence (RWE) solutions technology and applications and clinical solutions.